{
    "2019-11-30": [
        [
            {
                "time": "2023-10-07",
                "original_text": "国产白血病新药！复星医药FN-1501获美国FDA授予孤儿药资格认定，治疗急性髓性白血病(AML)",
                "features": {
                    "keywords": [
                        "复星医药",
                        "FN-1501",
                        "美国FDA",
                        "孤儿药资格认定",
                        "急性髓性白血病",
                        "AML"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}